Jiro Okami

7.9k total citations · 1 hit paper
156 papers, 5.0k citations indexed

About

Jiro Okami is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Jiro Okami has authored 156 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 117 papers in Pulmonary and Respiratory Medicine, 63 papers in Oncology and 28 papers in Surgery. Recurrent topics in Jiro Okami's work include Lung Cancer Diagnosis and Treatment (67 papers), Lung Cancer Treatments and Mutations (62 papers) and Lung Cancer Research Studies (15 papers). Jiro Okami is often cited by papers focused on Lung Cancer Diagnosis and Treatment (67 papers), Lung Cancer Treatments and Mutations (62 papers) and Lung Cancer Research Studies (15 papers). Jiro Okami collaborates with scholars based in Japan, United States and Italy. Jiro Okami's co-authors include Masahiko Higashiyama, Ken Kodama, Toshiteru Tokunaga, Kikuya Kato, Morito Monden, Jun Maeda, Hiroyuki Ito, Fumio Imamura, Kazuya Taniguchi and Hisao Asamura and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Jiro Okami

137 papers receiving 4.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial

2022 764 citations Morihito Okada, Masahiro Tsuboi et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Jiro Okami	3.0k	1.7k	943	904	827	156	5.0k
Michele Orditura	2.1k 0.7×	3.4k 2.0×	1.9k 2.0×	1.0k 1.1×	1.2k 1.5×	181	6.1k
Céline Mascaux	2.8k 0.9×	2.5k 1.5×	1.7k 1.8×	998 1.1×	245 0.3×	142	4.9k
Stephen L. Graziano	2.9k 1.0×	2.8k 1.7×	1.3k 1.3×	695 0.8×	459 0.6×	117	5.2k
Junming Zhu	4.3k 1.4×	4.1k 2.5×	1.8k 1.9×	879 1.0×	941 1.1×	29	7.3k
Robert Lim	1.4k 0.5×	3.1k 1.8×	1.3k 1.4×	1.1k 1.2×	534 0.6×	56	4.5k
Yuhchyau Chen	2.6k 0.8×	1.2k 0.7×	682 0.7×	551 0.6×	506 0.6×	120	4.4k
Hiroyuki Uetake	1.0k 0.3×	2.4k 1.4×	2.1k 2.2×	1.4k 1.5×	757 0.9×	200	4.9k
Yang Lü	971 0.3×	1.9k 1.1×	1.9k 2.1×	906 1.0×	491 0.6×	171	4.5k
Kyung-Hun Lee	2.0k 0.6×	4.1k 2.5×	1.6k 1.7×	1.5k 1.7×	706 0.9×	216	6.0k
Filippo Pietrantonio	1.5k 0.5×	2.9k 1.7×	1.1k 1.2×	1.2k 1.3×	1.1k 1.4×	298	5.0k

Countries citing papers authored by Jiro Okami

Since Specialization

Citations

This map shows the geographic impact of Jiro Okami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiro Okami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiro Okami more than expected).

Fields of papers citing papers by Jiro Okami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiro Okami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiro Okami. The network helps show where Jiro Okami may publish in the future.

Co-authorship network of co-authors of Jiro Okami

This figure shows the co-authorship network connecting the top 25 collaborators of Jiro Okami. A scholar is included among the top collaborators of Jiro Okami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiro Okami. Jiro Okami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kanzaki, Ryu, Ryo Tanaka, Tomohiro Maniwa, et al.. (2024). Long-term outcomes of surgical treatment of non-small cell lung cancer with oligometastatic disease involving only the brain in the era of PET/CT. Journal of Cardiothoracic Surgery. 19(1). 677–677. 1 indexed citations

Goto, Yoshihito, Yuichi Sakairi, Hidemi Suzuki, et al.. (2024). 1208MO Phase III trial of perioperative pirfenidone therapy for lung cancer with idiopathic pulmonary fibrosis (IPF): NEJ034 study. Annals of Oncology. 35. S776–S776.

Kayawake, Hidenao, Jiro Okami, Yasushi Shintani, et al.. (2024). Predictors of nodal upstaging in clinical N1 nonsmall cell lung cancer. Japanese Journal of Clinical Oncology. 55(3). 283–289.

Maniwa, Tomohiro, et al.. (2023). Extent of Lymph Node Dissection in Patients with Small-Sized Peripheral Non-Small Cell Lung Cancer during Intentional Segmentectomy. Annals of Thoracic and Cardiovascular Surgery. 29(6). 271–278. 5 indexed citations

Tanaka, Ryo, et al.. (2023). Analysis of liver metastases only at recurrence after resection of non-small cell lung cancer. The Journal of the Japanese Association for Chest Surgery. 37(6). 502–507.

Ose, Naoko, Jiro Okami, Koji Takami, et al.. (2023). Outcomes of surgical resection for pulmonary metastasis from pancreatic cancer. Surgery Today. 53(11). 1236–1246. 4 indexed citations

Mitsudomi, Tetsuya, Hiroyuki Ito, Morihito Okada, et al.. (2023). Neoadjuvant nivolumab plus chemotherapy in resectable non‐small‐cell lung cancer in Japanese patients from CheckMate 816. Cancer Science. 115(2). 540–554. 12 indexed citations

Kunimasa, Kei, Shingo Matsumoto, Takahisa Kawamura, et al.. (2023). Clinical application of the AMOY 9-in-1 panel to lung cancer patients. Lung Cancer. 179. 107190–107190. 20 indexed citations

Kato, Kikuya, Jiro Okami, Harumi Nakamura, et al.. (2023). Analytical Performance of a Highly Sensitive System to Detect Gene Variants Using Next-Generation Sequencing for Lung Cancer Companion Diagnostics. Diagnostics. 13(8). 1476–1476. 9 indexed citations

10.

Soh, Junichi, Shinichi Toyooka, Yasushi Shintani, et al.. (2022). Limited resection for stage IA radiologically invasive lung cancer: a real-world nationwide database study. European Journal of Cardio-Thoracic Surgery. 62(1). 22 indexed citations

11.

Yamauchi, Yoshikane, Masafumi Kawamura, Jiro Okami, et al.. (2022). Hazard Function Analysis of Recurrence in Patients with Curatively Resected Lung Cancer: Results from the Japanese Lung Cancer Registry in 2010. Cancers. 14(20). 5119–5119.

12.

Kimura, Tōru, Ryō Tanaka, Tomohiro Maniwa, et al.. (2021). Surgical indication of pulmonary metastasis arising from osteosarcoma or soft tissue sarcoma. General Thoracic and Cardiovascular Surgery. 70(3). 273–279. 1 indexed citations

13.

Kimura, Tōru, Masahiko Higashiyama, Keiichiro Honma, et al.. (2021). Long-term survival in thymic carcinoma with postoperative pleural dissemination. SHILAP Revista de lepidopterología. 7(1). 171–171. 1 indexed citations

14.

Saito, Tomohito, Tomohiro Murakawa, Yasushi Shintani, et al.. (2021). Preoperative renal dysfunction and long-term survival after surgery for non–small cell lung cancer. Journal of Thoracic and Cardiovascular Surgery. 164(1). 227–239.e6. 3 indexed citations

15.

Kondo, Jumpei, Hiroko Endo, Kanami Yamazaki, et al.. (2018). High‐throughput screening in colorectal cancer tissue‐originated spheroids. Cancer Science. 110(1). 345–355. 102 indexed citations

16.

Kumagai, Toru, Yasuhiko Tomita, Shin‐ichi Nakatsuka, et al.. (2018). HER3 expression is enhanced during progression of lung adenocarcinoma without EGFR mutation from stage 0 to IA1. Thoracic Cancer. 9(4). 466–471. 9 indexed citations

17.

Taniguchi, Kazuya, Junji Uchida, Kazumi Nishino, et al.. (2011). Quantitative Detection of EGFR Mutations in Circulating Tumor DNA Derived from Lung Adenocarcinomas. Clinical Cancer Research. 17(24). 7808–7815. 250 indexed citations

18.

Okami, Jiro, Masahiko Higashiyama, Hisao Asamura, et al.. (2009). Pulmonary Resection in Patients Aged 80 Years or Over with Clinical Stage I Non-small Cell Lung Cancer: Prognostic Factors for Overall Survival and Risk Factors for Postoperative Complications. Journal of Thoracic Oncology. 4(10). 1247–1253. 141 indexed citations

19.

Taniguchi, Kazuya, Jiro Okami, Ken Kodama, Masahiko Higashiyama, & Kikuya Kato. (2008). Intratumor heterogeneity of epidermal growth factor receptor mutations in lung cancer and its correlation to the response to gefitinib. Cancer Science. 99(5). 929–935. 217 indexed citations

20.

Kato, Kikuya, Kazuya Taniguchi, Jiro Okami, Ken Kodama, & Masahiko Higashiyama. (2006). Intratumor heterogeneity of EGFR mutations in lung cancer tissues and its correlation with the response to gefitinib. Clinical Cancer Research. 12. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact